CHIORAZZI, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 25.100
AS - Asia 15.002
EU - Europa 10.866
SA - Sud America 1.812
Continente sconosciuto - Info sul continente non disponibili 1.530
AF - Africa 301
OC - Oceania 77
Totale 54.688
Nazione #
US - Stati Uniti d'America 23.764
SG - Singapore 5.077
IT - Italia 3.046
CN - Cina 3.014
VN - Vietnam 2.981
HK - Hong Kong 1.592
DE - Germania 1.566
RU - Federazione Russa 1.443
BR - Brasile 1.329
CA - Canada 1.077
SE - Svezia 1.052
IE - Irlanda 817
GB - Regno Unito 606
UA - Ucraina 574
FR - Francia 556
IN - India 443
BD - Bangladesh 297
KR - Corea 282
FI - Finlandia 253
ID - Indonesia 221
AT - Austria 189
AR - Argentina 173
JP - Giappone 168
TR - Turchia 166
NL - Olanda 143
IQ - Iraq 128
DK - Danimarca 121
ES - Italia 106
MX - Messico 102
ZA - Sudafrica 99
PK - Pakistan 94
PL - Polonia 85
LT - Lituania 75
EC - Ecuador 70
PH - Filippine 70
SA - Arabia Saudita 70
CO - Colombia 68
CH - Svizzera 67
VE - Venezuela 59
AU - Australia 56
MY - Malesia 56
BE - Belgio 55
IR - Iran 42
AE - Emirati Arabi Uniti 34
UZ - Uzbekistan 33
CL - Cile 32
EG - Egitto 32
MA - Marocco 32
PY - Paraguay 32
TN - Tunisia 29
CR - Costa Rica 25
ET - Etiopia 25
JO - Giordania 25
KE - Kenya 25
EU - Europa 23
JM - Giamaica 23
TW - Taiwan 23
TH - Thailandia 22
HN - Honduras 21
KZ - Kazakistan 21
OM - Oman 21
NP - Nepal 20
NZ - Nuova Zelanda 20
PE - Perù 19
AZ - Azerbaigian 18
CZ - Repubblica Ceca 15
NI - Nicaragua 15
UY - Uruguay 15
BO - Bolivia 14
IL - Israele 14
PS - Palestinian Territory 14
DZ - Algeria 13
HU - Ungheria 13
TT - Trinidad e Tobago 13
AL - Albania 12
PA - Panama 12
RO - Romania 12
BG - Bulgaria 10
NG - Nigeria 10
SV - El Salvador 10
GT - Guatemala 8
KG - Kirghizistan 8
BH - Bahrain 7
DO - Repubblica Dominicana 7
HR - Croazia 7
SN - Senegal 7
AO - Angola 6
LB - Libano 6
MD - Moldavia 6
RS - Serbia 6
SY - Repubblica araba siriana 6
BB - Barbados 5
GR - Grecia 5
KW - Kuwait 5
LV - Lettonia 5
NO - Norvegia 5
BZ - Belize 4
CI - Costa d'Avorio 4
EE - Estonia 4
PR - Porto Rico 4
Totale 53.114
Città #
Singapore 3.152
Ann Arbor 2.860
Ashburn 2.413
San Jose 1.833
Dallas 1.604
Hong Kong 1.513
Milan 1.133
Ho Chi Minh City 875
Frankfurt am Main 816
Dublin 791
Woodbridge 775
Chandler 745
Toronto 717
Hanoi 692
Wilmington 649
Houston 626
Council Bluffs 611
New York 579
Fairfield 566
Jacksonville 558
Dearborn 547
Los Angeles 505
Santa Clara 471
Beijing 439
Chicago 337
Princeton 305
Boardman 298
Seattle 267
Hefei 252
The Dalles 252
Seoul 242
Nanjing 237
Rome 216
Columbus 201
Buffalo 180
Shanghai 179
Lauterbourg 167
Cambridge 163
Vienna 163
Jakarta 149
São Paulo 124
Guangzhou 110
Moscow 110
Orem 105
Phoenix 105
Helsinki 100
Da Nang 97
Tokyo 93
Dong Ket 92
Haiphong 92
Munich 92
Lachine 85
Lawrence 82
Montreal 80
Atlanta 75
Denver 74
Altamura 73
Chennai 73
Nanchang 73
Shenyang 73
Brooklyn 68
London 66
Hải Dương 63
Warsaw 60
Vilnius 58
Ha Long 57
Baghdad 55
Andover 52
Rio de Janeiro 52
Biên Hòa 50
Pune 50
Amsterdam 49
Carate Brianza 49
Washington 49
Zurich 49
Changsha 48
San Francisco 48
Stockholm 48
Hangzhou 47
Nuremberg 46
San Diego 46
Jinan 45
Can Tho 43
Falls Church 43
Johannesburg 43
Ottawa 43
Zhengzhou 43
Springfield 41
Basingstoke 40
Fremont 40
Ninh Bình 40
Philadelphia 40
Quận Bình Thạnh 40
Boston 39
Bắc Ninh 38
Florence 38
Jiaxing 38
Poplar 38
Brussels 37
Tianjin 37
Totale 32.762
Nome #
CIPN and its mechanism of development 671
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 601
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 536
Studio della neurotossicità periferica indotta da farmaci antitubulinici in modelli sperimentali in vitro e in vivo 533
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 526
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 493
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 487
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 477
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 461
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 459
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 454
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 447
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 446
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 441
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 439
Artificial apolipoprotein corona enables nanoparticle brain targeting 436
Age-related changes in the function and structure of the peripheral sensory pathway in mice 434
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 425
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 424
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 419
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 409
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 409
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 404
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 401
Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders 401
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 401
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 388
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 384
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 379
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 372
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 365
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 356
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 355
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 354
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 349
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 349
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 348
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 347
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 347
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 345
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 343
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 342
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 340
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 339
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 335
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 333
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 331
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 326
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 322
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 321
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 319
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 318
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 316
OCT2 transporter involvement in development of cisplatin toxicity 316
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 315
Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met 315
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 311
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 310
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 309
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 305
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 305
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 300
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 300
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 299
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 299
Addressing the Need of a Translational Approach in Peripheral Neuropathy Research: Morphology Meets Function 299
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 295
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 294
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 294
Multimodal experimental approach to the study of human neurological diseases 293
Engineered mesoporous silica-based nanoparticles as smart chemotherapy nanodevice for bortezomib administration 291
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 289
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 289
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 288
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 288
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 288
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 288
MSCs effect on Dark Agouti rats affected by chronic EAE 285
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 284
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 283
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 282
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 282
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 280
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 279
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models 279
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 278
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 278
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 277
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 276
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 272
BEHAVIOURAL AND MORPHOLOGICAL DESCRIPTION OF BORTEZOMIB-INDUCED PAINFUL NEUROPATHY IN RATS 272
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 272
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 271
The relevance of morphology in experimental oxaliplatin-induced peripheral neurotoxicity 271
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 269
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 269
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 269
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 269
Lipoplatin tm: a less neurotoxic formulation of cisplatin 268
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 268
Totale 34.870
Categoria #
all - tutte 164.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 164.026


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.389 0 0 0 177 139 181 95 106 82 143 134 332
2022/20233.423 389 830 372 325 249 529 63 179 272 51 103 61
2023/20242.946 95 97 97 143 386 712 501 163 156 68 68 460
2024/20257.844 447 891 711 363 617 292 508 280 891 1.028 662 1.154
2025/202622.326 2.949 1.858 2.441 1.768 1.942 1.266 2.841 1.061 1.702 1.743 1.310 1.445
2026/20274.699 953 906 2.248 592 0 0 0 0 0 0 0 0
Totale 54.688